SCHEMBL3463498

SCHEMBL3463498

c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)cc2)c2cccc3ccccc23)cc1.c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.46
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 5/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
CYP2A6 P11509 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.35
APP P05067 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KEAP1 Q14145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29449967 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL6481487 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL15807471 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL75887 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL6123830 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL17690821 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL13854486 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL23047 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL76513 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL29349638 1.00 SIGMAR1 (0.46) SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020130592-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME 서울대학교산학협력단 2020-06-25 WO disclosed
US-10418560-B2 Organic light emitting diode device SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-17 US disclosed
US-20180261791-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2018-09-13 US disclosed
US-20170222154-A1 ORGANIC LIGHT EMITTING DIODE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-03 US disclosed
US-20160126479-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-05 US disclosed
EP-2259362-B1 Organic light emitting diode SAMSUNG DISPLAY CO LTD (KR) 2012-10-10 EP disclosed
EP-2259362-A1 Organic light emitting diode Samsung Mobile Display Co., Ltd. (KR) 2010-12-08 EP disclosed
WO-2010110553-A2 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOW ADVANCED DISPLAY MATERIALS, LTD. (KR) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126479-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME ODC1, AOX1, CYP1B1 SIGMAR1 264/4885L3MBTL1 500/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.